SBIR/STTR Research Award

RNAI IN MAMMALIAN CELLS

Award identifier 460b3a5d5b0932986d0469259babd8a0d2dca9c92567a261ab1ba9aed0417aefAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
GENETICA, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

In a diverse group of organisms ranging from plants to vertebrates, double-stranded RNA can silence gene expression in a sequence specific manner. We have made substantial progress in deciphering the mechanism underlying this phenomenon which has been termed variously RNA interference (RNAi) or post-transcriptional gene silencing. In this application, we propose to develop RNAi as a tool for analyzing gene function in mammalian cells. Recent data has suggested that dsRNA can suppress gene expression in Chinese Hamster Ovary cells. We will use approaches similar to those which we have previously used in Drosophila to determine whether this effect occurs through and RNAi mechanism. If so, we propose to develop tools which will allow the use of RNAi in CHO cells for probing gene function. Using CHO cells as a starting point, and incorporating our ever-advancing understanding of the RNAi mechanism, our ultimate goal is to reconstitute the RNAi machinery in a broad range of mammalian cell types. In this Phase I application, we will test whether ectopic expression of components of the RNAi machinery that we have already identified can convert cells to an RNAi competent state. Furthermore, we will develop a strategy for executing an unbiased screen for activation of RNAi in mammalian cells. PROPOSED COMMERCIAL APPLICATION: With accumulating genomic information, novel technologies are required to speed analysis of gene function in the post-genomic era. While approaches for creating loss-of-function mutations in mammals do exist, they are cumbersome, time consuming and technically difficult. The development of facile gene silencing methodology for cultured mammalian cells and animals would revolutionize biology.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.